Skip to main content
. Author manuscript; available in PMC: 2012 Nov 20.
Published in final edited form as: Sci Transl Med. 2011 Aug 17;3(96):96ra77. doi: 10.1126/scitranslmed.3001318

Table 2.

Significant Drug Clusters Described in Text. Drugs were clustered in an unsupervised manner by their predicted therapeutic score across 100 diseases (See Fig.3a)

Drug Group Drugs
PI3K Inhibitors LY−294002 and wortmannin
HSP90 geldanamycin, raloxifene, monorden, and sodium phenylbutyrate
HDAC Inhibitors vorinostat, HC toxin, and trichostatin A
Salicylate anti-inflammatory sulfasalazine, mesalazine, and acetylsalicylic acid